JC
CELG

JBF Capital’s Celgene Corp CELG Stock Holding History

JBF Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-60,000
Closed -$5.15M – 95
2014
Q2 		$5.15M Buy
+60,000
New +$4.56M 0.76% 7
2014
Q1 		– Sell
-8,380
Closed -$708K – 124
2013
Q4 		$708K Buy
+8,380
New +$663K 0.11% 54

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JBF Capital's CELG Position: Q3 2014 in Review

JBF Capital sold out of Celgene Corp (CELG) in Q3 2014, closing a stake of 60,000 shares — an estimated $5.15M sold.

JBF Capital first reported a position in CELG in Q4 2013 and held it in 2 quarters. The position peaked at $5.15M in Q2 2014. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

  • JBF Capital reported no remaining Celgene Corp position as of Q3 2014 after selling out during the quarter.
  • JBF Capital sold 60,000 Celgene Corp shares in Q3 2014, an estimated $5.15M.
  • JBF Capital first reported a position in Celgene Corp in Q4 2013 and held it in 2 quarters.
  • JBF Capital's Celgene Corp position peaked at $5.15M in Q2 2014.
  • 1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on JBF Capital's 13F filing for Q3 2014, filed 16 Oct 2014.